Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

This content is for healthcare professionals only.

Please confirm you are a healthcare professional.

Yes
No
iwNHL 2020 Session III

Novel Therapies Part I

Presentations
Novel ADCs
Laurie Sehn
11 September, 2020
CD20 / CD3 bispecific antibodies: How to choose?
Martin Hutchings, MD, PhD, The Finsen Center, National Hospital Copenhagen University Hospital, Copenhagen
11 September, 2020
Oral PI3K delta (δ) inhibitors in lymphoma
Jennifer Brown, MD, PhD, Dana-Farber Cancer Institute, Boston, MA
11 September, 2020
Previous session View all sessions Next session
The content of VJHemOnc is intended for healthcare professionals